Search research articles
Contact Us
Filters
Showing results (21-30 of 44) with videos related to
Page
of 5
Sort By:
Current Oncology (Toronto, Ont.)
|
May 27, 2022
Using a Weekly Patient-Reported Outcome Questionnaire to Track Acute Toxicity in Patients Undergoing Pelvic Radiotherapy for Gynecologic Cancers
Matthew Chan, Robert Olson, Vincent Lapointe, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
July 9, 2017
The impact of comorbidities on the benefits of prolonged androgen ablation in patients with T3-4 prostate cancer treated with external beam radiation therapy
Eric Tran, Matthew Paquette, Justin Jay, et al.
Brachytherapy
|
April 2, 2020
The addition of interstitial needles to intracavitary applicators in the treatment of locally advanced cervical cancer: Why is this important and how to implement in low- and middle-income countries?
Dorothy Lombe, Juanita Crook, Francois Bachand, et al.
American Journal of Clinical Oncology
|
January 26, 2022
The Prognostic Impact of Radiotherapy Delays in Oropharynx Carcinoma and the Role of p16 Status
Ryan Urban, Fatimah Alfaraj, Robert Olson, et al.
American Journal of Surgery
|
January 23, 2016
The accuracy of endorectal ultrasound in staging rectal lesions in patients undergoing transanal endoscopic microsurgery
Marisa Leon-Carlyle, Jacqueline A Brown, Jeremy Hamm, et al.
Brachytherapy
|
March 15, 2011
The effect of loose versus stranded seeds on biochemical no evidence of disease in patients with carcinoma of the prostate treated with iodine-125 brachytherapy
Christopher Herbert, W James Morris, Jeremy Hamm, et al.
Annals of Surgical Oncology
|
June 26, 2023
Breast-Conserving Therapy is Associated with Improved Survival Without an Increased Risk of Locoregional Recurrence Compared with Mastectomy in Both Clinically Node-Positive and Node-Negative Breast Cancer Patients
Elizaveta Vasilyeva, Jeremy Hamm, Alan Nichol, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
February 14, 2012
Outcomes following iodine-125 brachytherapy in patients with Gleason 7, intermediate risk prostate cancer: a population-based cohort study
Christopher Herbert, W James Morris, Mira Keyes, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
February 3, 2018
The TEACHH model to predict life expectancy in patients presenting for palliative spine radiotherapy: external validation and comparison with alternate models
Maryam Dosani, Scott Tyldesley, Brendan Bakos, et al.
International Journal of Radiation Oncology, Biology, Physics
|
December 17, 2013
Prostate-specific antigen at 4 to 5 years after low-dose-rate prostate brachytherapy is a strong predictor of disease-free survival
Andrea C Lo, W James Morris, Vincent Lapointe, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 44) with videos related to
Sort By:
Page
of 5
Current Oncology (Toronto, Ont.)
|
May 27, 2022
Using a Weekly Patient-Reported Outcome Questionnaire to Track Acute Toxicity in Patients Undergoing Pelvic Radiotherapy for Gynecologic Cancers
Matthew Chan, Robert Olson, Vincent Lapointe, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
July 9, 2017
The impact of comorbidities on the benefits of prolonged androgen ablation in patients with T3-4 prostate cancer treated with external beam radiation therapy
Eric Tran, Matthew Paquette, Justin Jay, et al.
Brachytherapy
|
April 2, 2020
The addition of interstitial needles to intracavitary applicators in the treatment of locally advanced cervical cancer: Why is this important and how to implement in low- and middle-income countries?
Dorothy Lombe, Juanita Crook, Francois Bachand, et al.
American Journal of Clinical Oncology
|
January 26, 2022
The Prognostic Impact of Radiotherapy Delays in Oropharynx Carcinoma and the Role of p16 Status
Ryan Urban, Fatimah Alfaraj, Robert Olson, et al.
American Journal of Surgery
|
January 23, 2016
The accuracy of endorectal ultrasound in staging rectal lesions in patients undergoing transanal endoscopic microsurgery
Marisa Leon-Carlyle, Jacqueline A Brown, Jeremy Hamm, et al.
Brachytherapy
|
March 15, 2011
The effect of loose versus stranded seeds on biochemical no evidence of disease in patients with carcinoma of the prostate treated with iodine-125 brachytherapy
Christopher Herbert, W James Morris, Jeremy Hamm, et al.
Annals of Surgical Oncology
|
June 26, 2023
Breast-Conserving Therapy is Associated with Improved Survival Without an Increased Risk of Locoregional Recurrence Compared with Mastectomy in Both Clinically Node-Positive and Node-Negative Breast Cancer Patients
Elizaveta Vasilyeva, Jeremy Hamm, Alan Nichol, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
February 14, 2012
Outcomes following iodine-125 brachytherapy in patients with Gleason 7, intermediate risk prostate cancer: a population-based cohort study
Christopher Herbert, W James Morris, Mira Keyes, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
February 3, 2018
The TEACHH model to predict life expectancy in patients presenting for palliative spine radiotherapy: external validation and comparison with alternate models
Maryam Dosani, Scott Tyldesley, Brendan Bakos, et al.
International Journal of Radiation Oncology, Biology, Physics
|
December 17, 2013
Prostate-specific antigen at 4 to 5 years after low-dose-rate prostate brachytherapy is a strong predictor of disease-free survival
Andrea C Lo, W James Morris, Vincent Lapointe, et al.
Page
of 5